Navigation Links
Interview of the Vice President
Date:12/6/2007

t, and we ought to be able to pass an emergency supplemental, as we've done in years past, to make certain that the troops have got what they need in the field, the department can run efficiently, that the investments that are required to sustain the effort that I think obviously is bearing fruit in Iraq needs to go forward.

I'm puzzled why they are so wedded to their political view that Nancy Pelosi and Harry Reid aren't going to move that legislation -- said, absolutely not, there won't be another vote on this matter in this Congress. I think that's a big mistake.

I'm also somewhat surprised -- I look at the House -- there are members of the House I worked closely with over the years when I was Secretary of Defense who would ordinarily have been staunch advocates for this kind of legislation, who no longer are staunch advocates -- and I'm referring to my friend, Jack Murtha -- I think of all of them as friends of mine -- but Jack and other senior leaders who now all march to the tune of Nancy Pelosi, to an extent I had not seen, frankly, with any previous Speaker. And I'm surprised by that. I think of John Dingell and the energy business. This is a hot item right now. But I don't see John Dingell driving that train. It looks to me like Nancy Pelosi is driving that train. And that is -- well, it's surprising when I think of the -- I'm trying to think how to say all of this in a gentlemanly fashion -- but the Congress I served in, that wouldn't have happened. We would not have had a Speaker who, from my perspective, is that far out of the sort of mainstream -- she is a San Francisco Democrat, certainly entitled to her views, but able to dictate policy as effectively as she apparently does to the rest of the caucus.

Q Well, did any of those guys lose their spine? Is that what you're saying?

THE VICE PRESIDENT: I was being very diplomatic in the way I phrased it. (Laughter.) They're not carrying the big stick I would have expected with the
'/>"/>

SOURCE White House Press Office
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
3. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
4. American Board of Internal Medicine President Named to Alzheimers Study Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...o take body temperature, for home,and clinical use...- Kidz-Med, Inc.,(subsidiary of American Scientifi... distributor of the Thermofocus(R) 5-in-1 non-cont...s of a clinical study,conducted by the Second Chil..., Italy, which proves that the Thermofocus(R) meas...
(Date:7/23/2008)... Therapy to Treat the Disease -, WAYNE, N.J. and ... --,Bayer HealthCare Pharmaceuticals and Onyx Phar...hat The New England Journal of Medicine published,...var(R) (sorafenib),tablets decreased the absolute ...ectable hepatocellular carcinoma (HCC), or liver c...
(Date:7/23/2008)...wswire/ -- The following was,released by the U.S. ... Member Smith, and Members of the Committee.,Thank... I appeared before this Committee almost six month...he talented and dedicated professionals,at the Jus...ave come to,appreciate that much more deeply their...
(Date:7/23/2008)...-- InCode BioPharmaceutics, Inc.,an emerging biop... test,results demonstrating the utility of their l...rare chronic blood disorder paroxysmal nocturnal,h...presented at the XXII,International Complement Wor... The only treatment currently available for PNH pa...
Breaking Medicine Technology:Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Pharsight to Present on IVIVC at Bioequivalence 26 Bioavailability Strategies Conference 6142 1Pharsight to Present on IVIVC at Bioequivalence 26 Bioavailability Strategies Conference 6142 2Pharsight to Present on IVIVC at Bioequivalence 26 Bioavailability Strategies Conference 6142 3Immune Design Announces 2418 Million Series A Financing 22475 1Immune Design Announces 2418 Million Series A Financing 22475 2Immune Design Announces 2418 Million Series A Financing 22475 3John 26 Jean Piety Named SLA Engineering Librarians of the Year 22473 1John 26 Jean Piety Named SLA Engineering Librarians of the Year 22473 2Chiltern Enhances Its Portfolio of Electronic Data Capture 28EDC 29 Services With the Addition of Hosting and eCRF Design Services for DataLabs 28by 22470 1Chiltern Enhances Its Portfolio of Electronic Data Capture 28EDC 29 Services With the Addition of Hosting and eCRF Design Services for DataLabs 28by 22470 2
...tionality in Humans of CTI,s,Programmable, Pulsati...onoDose, BASEL, Switzerland and TRENTON, N.J., May... (CTI) announced today the successful,completion o...rammable, pulsatile, passive transdermal drug/devi...s to publish this,clinical data in leading scienti...
...IRE)--May 7, 2007 - NanoViricides,Inc. (Pink Shee...es,against rabies and BSL3 in vitro studies agains...rd Annual Symposium of the Pan,American Society fo...y 2. (Pan American Society for Clinical Virology (...dies against Clade 2 H5N1, a Dec. 2006 isolate in,...
Other Medicine Technology:Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device,Combination Product - ChronoDose 2Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device,Combination Product - ChronoDose 3NanoViricides Drugs Found To Be Highly Effective Against Most,Recent Strain of the H5N1 Avian Flu Virus 2
(Date:7/25/2008)...er Releases Results of Fourth Annual Physician On-...DETROIT, July 25 /PRNewswire/ -- Sullivan, Cotter ...al survey of physician on-call pay rates and,pract.... The survey report,with data from 132 healthcare...all pay practices and rates paid for 33 physician ...
(Date:7/25/2008)...ionship Based on Significant Improvements in Membe...tacor, Inc., a leader in health,care quality manag...day,announced it has entered into a long-term agre...ellmark,s Collaboration on Quality(SM) Incent and,...between Wellmark and,primary care clinicians to pr...
(Date:7/25/2008)...ly 25 /PRNewswire/ -- The Elekta Family of Compani...ment solutions at the 2008,American Association of...onstrating how the joint forces of Elekta, IMPAC a...py planning and delivery solutions that,streamline...ce for,patients, as well as enhance clinician effi...
(Date:7/25/2008)...id back-up in esophagus can cause immune system ch...s) -- The first evidence linking gastroesophageal ...ed by Duke University Medical Center researchers. ... first noted in the 1970s, and since then studies ...of asthma patients also experience GERD symptoms. ...
Breaking Medicine News(10 mins):Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2
...the risk of heart disease, but now researchers say...r the development of a heart attack.This is becaus... almost immediate impact on the cardiovascular sys...ents, the researchers found that those who smoked ...
...chool of Medicine have recently found that the bra...hat lets us stop smelling something, even though t... recent issue of the journal Science show that a p...‘nose’ of odour receptor cells.//The main job of t...
...inking could reduce their risk of suffering a stro.... In a new leaflet, the Stroke Association says sm...ic strokes - caused by blood clots blocking arteri...es of the brain attack.// Alcohol thins the blood...
...he South Sea Islands. It is a herb that has been i...ses. The herb is commonly used by consumers as a g...ress and muscle spasms. According to experts, the ...wn as// benzodiazepines but is not chemically rela...
Other Medicine News:
...Ovulation Predicting Test is a qualitative immunoa...e (hLH) in human urine to predict the occurrence o...on of human luteinizing hormone (hLH). Usually, ar...rief, significant rapid increase called the "LH su...
The Shandon Cryotome SME Cryostat model is a sophisticated, top of the line cryostat that combines automated electronic advance and hands-free sectioning with fully independent specimen temperature c
The Shandon Linistat Linear Stainer is a compact answer to H&E frozen section protocols, with a footprint that fits on top of most cryostas to streamline workflow during frozen sectioning.
The Shandon Varistain Gemini is designed for high throughput, precision, safety, durability and ultimate flexibility in histology and cytology staining applications. It features load-on-demand multip
Medicine Products: